Custom Insole With Transcutaneous Electrical Nerve Stimulation on Clinical Outcomes of Diabetic Foot Ulcers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Lahore

About this trial

Diabetic foot ulcers (DFUs) are one of the serious complications of diabetes, typically resulting from neuropathy or peripheral arterial disease, and can often lead to amputation. It affects approximately 6.3% of people with diabetes globally. In Pakistan, the overall prevalence of DFUs is 16.83%, with a slightly higher rate in females. Diabetic foot ulcers are the main reason for lower extremity amputation (LEA) with non-traumatic origin, hospitalization, healthcare costs, and mortality.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

≥ 18 years old with type 1 and 2 diabetes

Both Males and Females

Having Foot ulcers in Grade 1 and Grade 2 according to the Wagner Classification

Disqualifiers

History of amputation (proximal to the trans-metatarsal joint)

Active or inactive Charcot foot

Non-constructible peripheral vascular disease secondary to arteriosclerosis (AS)

Leg length discrepancy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standard Care Only

    Other intervention

    Standard care includes routine wound debridement, moist wound dressings infection control, glycemic management, vascular assessment, and patient education in line with international DFU management guidelines.

  • Custom Insole + Standard Care

    Other intervention

    The experimental group will receive customised polyethene foam insoles with a Poron top layer along with standard care.

  • TENS + Custom Insole + Standard Care

    Other intervention

    Participants in this group will receive a combination of transcutaneous electrical nerve stimulation (TENS), custom-made insole therapy, and standard care for diabetic foot ulcers (DFUs).

Treatment groups

159 Participants
are divided into 3 treatment groups
Group A: Standard Care OnlyOther 1 intervention
Group B: Custom Insole + Standard CareExperimental treatment 1 intervention
Group C: TENS + Custom Insole + Standard CareExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Wound Healing

Patients will be assessed for ulcer dimensions by using a simple ruler method. Length and width will be noted using a simple ruler method.

Time frame
Wound dimensions will be measured at baseline, and change in length and width will be measured at the 4th week, 8th week, and 12th week of the treatment session.

Secondary outcomes

1

Risk of fall

The Tinetti Scale will be used to measure the risk of fall. The final score of the scale is 28 points, and the interpretation is as follows: 25-28 = low risk of falls; 19-24 = moderate risk of falls; and \<19 = high risk of falls.

Time frame
Risk of fall will be measured at baseline, and change in status will be measured at the 4th week, 8th week, and 12th week of the treatment session.
2

Dynamic Balance:

The time up and go (TUG) scale will be used for measuring dynamic balance. A time score of ≤10 seconds is considered normal, and a time of ≥14 seconds has been shown to indicate a high risk of falls.

Time frame
Change in status of dynamic balance will be measured at 4th week, at 8th week and 12th week of treatment.
3

Pain Intensity

Pain intensity will be measured using a visual analogue scale. It is an 11-point scale where "0" indicates no pain and "10" indicates the worst possible pain.

Time frame
Pain intensity will be measured at baseline, and change in pain intensity will be measured at 4th week, 8th week, and 12th week.
4

Toe Muscle Strength

The paper grip test (PGT) will be used to measure toe muscle strength.

Time frame
Toe Muscle Strength will be measured at baseline, and change in strength will be measured at the 4th week, 8th week, and 12th week of the treatment session.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.